Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,835Open textbooks209Open-access articles1,406Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology182Genetics and Genomics170Neuroscience185Cardiovascular Medicine180Immunology142Pharmacology173Molecular Biology161Infectious Diseases150Rare and Inherited Diseases181Clinical Research173Anatomy and Physiology613Drugs and Chemicals621Psychiatry and Psychology185Public Health and Nutrition178Diagnostics and Medical Technology125Respiratory Medicine113Digestive System and Liver91Metabolism and Endocrine Disease177Bones, Joints, Muscles and Skin213Kidney, Urology and Women's Health173Eye, Ear, Nose and Throat55
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Public Health and Nutrition›Epidemics

Continue where you left off ()

Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Epidemics

Public Health and Nutrition · NLM MeSH · updated 2026-11-04 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 3 min read

Sudden outbreaks of a disease in a country or region not previously recognized in that area, or a rapid increase in the number of new cases of a previous existing endemic disease.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. Full-text reviews7. References8. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (584 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

Sudden outbreaks of a disease in a country or region not previously recognized in that area, or a rapid increase in the number of new cases of a previous existing endemic disease. Epidemics can also refer to outbreaks of disease in animal or plant populations.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Where it fits in the MeSH classification

Broader topics
Disease Outbreaks
Narrower topics
Opioid Epidemic; Pandemics

Research landscape

PubMed indexes 162,225 records tagged with the MeSH heading “Epidemics” (counts retrieved 2026-10-31). 146,810 of them (90.5%) were published from 2020 onward, and the busiest period so far is 2020 onward with 146,810 records.

Reviews account for 20,316 records (12.5%) and meta-analyses for 1,463. Randomized controlled trials number 1,244 (0.8%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 3,572 records; 2000-2009: 86 records; 2010-2019: 11,757 records; 2020 onward: 146,810 records3,572through 1999862000-200911,7572010-2019146,8102020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19993,572
2000-200986
2010-201911,757
2020 onward146,810
Share of records by publication typeReviews: 12.5 percent; Meta-analyses: 0.9 percent; Randomized controlled trials: 0.8 percentReviews12.5% (20,316)Meta-analyses0.9% (1,463)Randomized controlled trials0.8% (1,244)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 162,225 PubMed records
TypeRecordsShare
Reviews20,31612.5%
Meta-analyses1,4630.9%
Randomized controlled trials1,2440.8%

Method: PubMed query "Epidemics"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in public health and nutrition

Population and nutrition studies mostly observe what people eat, breathe or are exposed to and then look for links with health, which shows association and not proof of cause. Self-reported diet is imprecise, people who eat or live differently also differ in other ways, and effects measured across a population may not apply to one person. Check the study design, how exposure was measured, what else was accounted for and the size of the effect, not only whether it was statistically significant.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
The theory of epidemics with altruism
Lynch MP, Schnyder SK, Molina JJ, Yamamoto R, Turner MS
2026Research article
Design not recorded in structured metadata
3cc by
PMID 41758666 · DOI · PMC12956880
Graph neural network surrogates to leverage mechanistic expert knowledge towards reliable and immediate pandemic response
Schmidt A, Zunker H, Heinlein A, Kühn MJ
2026Research article
Design not recorded in structured metadata
3cc by
PMID 41688640 · DOI · PMC12904856
Optimizing infectious disease mitigation under dynamic conditions
Müller L, Sartori F, Dehning J, Eggl MF, Priesemann V
2026Research article
Design not recorded in structured metadata
2cc by
PMID 42546195 · DOI · PMC13462870

The theory of epidemics with altruism [1]

Research article Lynch MP, Schnyder SK, Molina JJ, Yamamoto R, Turner MS · · 2026 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Social distancing can mitigate the spread of diseases in humans and animals.
Closing excerpt
The resulting behavior, while emerging from a complex optimization problem, is simple enough that it could have evolved as a behavioral response in social animals, as well as being easy to communicate and understand for humans.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (199 words)

Social distancing can mitigate the spread of diseases in humans and animals. Social distancing allows susceptible individuals to protect themselves (and others) but confers no personal benefit for infected individuals if recovery provides immunity. However, individuals are likely to be at least weakly altruistic and may be interested in protecting others when infected. A strongly altruistic population where individuals value others as equal to themselves would be expected to self-isolate when infected. This would strongly suppress the disease, avoid Herd Immunity, and vastly improve outcomes. Still, little is known about how weaker altruism affects behavior during epidemics. Here we show using game theory that even extremely weakly altruistic individuals, valuing their own lives equivalent to roughly 100,000 others, can rationally achieve almost identical outcomes. Individuals self-isolate in order to avoid setting off chains of infections that they would perceive as costly to them even at such small altruism. Our results are robust to a moderate fraction of asymptomatic cases or completely selfish individuals. The resulting behavior, while emerging from a complex optimization problem, is simple enough that it could have evolved as a behavioral response in social animals, as well as being easy to communicate and understand for humans.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41758666 · DOI · PMC12956880

Graph neural network surrogates to leverage mechanistic expert knowledge towards reliable and immediate pandemic response [2]

Research article Schmidt A, Zunker H, Heinlein A, Kühn MJ · · 2026 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
During the COVID-19 crisis, mechanistic models have guided evidence-based decision making.
Closing excerpt
These results show how GNN surrogates can translate complex metapopulation models into immediate, reliable tools for pandemic response.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (195 words)

During the COVID-19 crisis, mechanistic models have guided evidence-based decision making. However, time-critical decisions in a dynamical environment limit the time available to gather supporting evidence. We address this bottleneck by developing a graph neural network (GNN) surrogate of an age-structured and spatially resolved mechanistic metapopulation simulation model. This combined approach complements classical modeling approaches which are mostly mechanistic and purely data-driven machine learning approaches which are often black box. Our design of experiments spans outbreak and persistent-threat regimes, up to three contact change points, and age-structured contact matrices on a spatial graph with 400 nodes representing German counties. We benchmark multiple GNN layers and identify an ARMAConv-based architecture that offers a strong accuracy–runtime trade-off. Across horizons of 30–90 day simulation and prediction, allowing up to three contact change points, the surrogate model attains 10–27% mean absolute percentage error (MAPE) while delivering (near) constant runtime with respect to the forecast horizon. Our approach accelerates evaluation by up to 28 670 times compared with the mechanistic model, allowing responsive decision support in time-critical scenarios and straightforward web integration. These results show how GNN surrogates can translate complex metapopulation models into immediate, reliable tools for pandemic response.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41688640 · DOI · PMC12904856

Optimizing infectious disease mitigation under dynamic conditions [3]

Research article Müller L, Sartori F, Dehning J, Eggl MF, Priesemann V · · 2026 · cited 2 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Mitigation measures are essential for controlling the spread of infectious diseases during pandemics and epidemics, but they impose considerable societal, individual, and economic costs.
Closing excerpt
Overall, our framework is easily applicable to general and complex settings and thereby presents a versatile tool to explore optimal mitigation strategies for endemic and pandemic infectious disease.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (190 words)

Mitigation measures are essential for controlling the spread of infectious diseases during pandemics and epidemics, but they impose considerable societal, individual, and economic costs. We developed a general framework that combines simulation of disease dynamics with optimal control to determine mitigation strategies that balance infection and mitigation costs. Optimizing this trade-off, we identified three surprising effects: first, assuming a constant reproduction number [Formula: see text], the optimal response is typically "all-or-nothing": depending on disease severity, either strict mitigation or none at all is optimal, with intermediate levels emerging only in restricted regimes that we characterize analytically. Second, under seasonal variations, optimal mitigation is stricter during winter. Interestingly, a single wave of infections still arises in spring, replacing the autumn/winter waves known for classical influenza. Third, during steady vaccination campaigns, even optimal mitigation can result in transient infection waves. Finally, we quantify the cost of delayed mitigation onset and show that even short delays can substantially increase total costs-if the disease is severe. Overall, our framework is easily applicable to general and complex settings and thereby presents a versatile tool to explore optimal mitigation strategies for endemic and pandemic infectious disease.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42546195 · DOI · PMC13462870

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis [4]
    Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. · Lancet · 2020 · cited 2,519 times (Europe PMC)
  • Research article Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis [5]
    Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. · Global Health · 2020 · cited 2,091 times (Europe PMC)
  • Research article Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis [6]
    Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. · Gastroenterology · 2020 · cited 1,151 times (Europe PMC)
  • Research article COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis [7]
    Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. · J Med Virol · 2020 · cited 856 times (Europe PMC)
  • Research article Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis [8]
    Wu T, Jia X, Shi H, Niu J, Yin X, Xie J, et al. · J Affect Disord · 2021 · cited 779 times (Europe PMC)
  • Research article A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic in 2020 [9]
    Robinson E, Sutin AR, Daly M, Jones A · J Affect Disord · 2022 · cited 766 times (Europe PMC)

Full-text reviews on EvidenceLib

Open-access review articles about this topic, reproduced in full with authors, licence and references.

  • Demographic, regional and temporal trends of hyperuricemia epidemics in mainland China from 2000 to 2019: a systematic review and meta-analysis

    Yang Li, Ziyan Shen, Bowen Zhu et al. · Global Health Action 2021 · CC BY 4.0

References

  1. Lynch MP, Schnyder SK, Molina JJ, Yamamoto R, Turner MS. The theory of epidemics with altruism. . 2026. PMID 41758666 · DOI · PMC12956880
  2. Schmidt A, Zunker H, Heinlein A, Kühn MJ. Graph neural network surrogates to leverage mechanistic expert knowledge towards reliable and immediate pandemic response. . 2026. PMID 41688640 · DOI · PMC12904856
  3. Müller L, Sartori F, Dehning J, Eggl MF, Priesemann V. Optimizing infectious disease mitigation under dynamic conditions. . 2026. PMID 42546195 · DOI · PMC13462870
  4. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al.. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020. PMID 32497510 · DOI · PMC7263814
  5. Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al.. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020. PMID 32631403 · DOI · PMC7338126
  6. Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al.. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology. 2020. PMID 32251668 · DOI · PMC7194936
  7. Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al.. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020. PMID 32162702 · DOI · PMC7228329
  8. Wu T, Jia X, Shi H, Niu J, Yin X, Xie J, et al.. Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis. J Affect Disord. 2021. PMID 33310451 · DOI · PMC7710473
  9. Robinson E, Sutin AR, Daly M, Jones A. A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic in 2020. J Affect Disord. 2022. PMID 34600966 · DOI · PMC8578001

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-11-04; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-11-04.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Opioid EpidemicPublic Health and Nutrition
  • PandemicsPublic Health and Nutrition
  • Age DistributionPublic Health and Nutrition
  • Age of OnsetPublic Health and Nutrition
  • AirPublic Health and Nutrition
  • Air ConditioningPublic Health and Nutrition

All 114 articles in Public Health and Nutrition →

At a glance

162,225
PubMed records on this heading
90%
published since 2020
20,316
review articles
1,244
randomized trials
9
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Opioid EpidemicPublic Health and Nutrition
  • PandemicsPublic Health and Nutrition
  • Age DistributionPublic Health and Nutrition
  • Age of OnsetPublic Health and Nutrition
  • AirPublic Health and Nutrition

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Rights and removal requests · Legal · Support